CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd

BSE 524636 OXYGENTAPH INE102E01018
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

13 filings · 3 material · busiest 2026-07-27 and 2026-07-30

What it files

AGM / EGM4 Board Meeting2 General1 Annual Report1 Board Outcome1 Results1 Change in Management1 Compliance Certificate1

Filings

13 in the window

  1. 21 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 33rd Annual General Meeting held on 21.08.2026.

    AGM/EGM / AGM View filing →

  2. 21 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

    AGM/EGM / AGM View filing →

  3. 31 July 2026

    General

    Newspaper Advertisement

    Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026.

    Company Update / General View filing →

  4. 30 July 2026

    AGM / EGM

    Submission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.

    Notice of 33rd Annual General Meeting for the Financial Year 2025-26.

    AGM/EGM / AGM View filing →

  5. 30 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015

    Others / Reg. 34 (1) Annual Report View filing →

  6. 30 July 2026

    AGM / EGM

    Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.

    Intimation of Book Closure and Cut-off Date for the AGM

    AGM/EGM / AGM View filing →

  7. 27 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome For The Board Meeting Held On 27.07.2026

    Un-audited Financial results for the Quarter ended 30.06.2026.

    Board Meeting / Outcome of Board Meeting View filing →

  8. 27 July 2026

    Results

    Un-Audited Results For The Quarter Ended 30.06.2026.

    Un-audited Financial Results for the Quarter ended 30.06.2026.

    Result / Financial Results View filing →

  9. 27 July 2026

    Change in Management

    Change in Management

    Appointment of Cost Auditor for the Financial Year 2026-27.

    Company Update / Change in Management View filing →

  10. 24 July 2026

    Board Meeting

    Update on board meeting

    The Board Meeting to be held on 25/07/2026 has been revised to 27/07/2026 Postponement of the Board Meeting to be held on Saturday, 25th July, 2026 and rescheduling of the board meeting ....

    Company Update / Board Meeting Rescheduled View filing →

  11. 22 July 2026

    Board Meeting

    Board Meeting Intimation for The Meeting To Be Held On Saturday, 25Th Day Of July, 2026

    Oxygenta Pharmaceutical Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  12. 14 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance as per Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  13. 24 June 2026

    Trading Window

    Closure of Trading Window

    Closure of trading window for the period ending 30.06.2026.

    Insider Trading / SAST / Closure of Trading Window View filing →